Medtronic recalled 348,616 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators because they might fail to deliver energy when high voltage therapy is needed, the FDA said July 18.
Read the full post on Becker's Hospital Review - Healthcare News
